[Form 4] Cerence Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cerence Inc. insider sale reported. Christian Mentz, EVP and Chief Revenue Officer, sold 4,000 shares of Cerence common stock on 08/14/2025 at a reported price of $12.7358 per share. After the sale, Mr. Mentz beneficially owned 138,747 shares, held directly. The Form 4 was signed by an attorney-in-fact, Jennifer Salinas, on 08/18/2025 and states the transaction represents shares sold by the reporting person.

Positive

• Disclosure compliance: The Form 4 reports the sale with transaction date, price, and post-sale holdings.
• Substantial retained ownership: Reporting person continues to hold 138,747 shares after the sale, indicating a meaningful ongoing equity stake.

Negative

• Insider sale: The officer sold 4,000 shares, which may be viewed negatively by some investors despite being modest relative to total holdings.

Insights

Securities Analyst

TL;DR Routine officer sale of a modest number of shares; holdings remain substantial.

The Form 4 discloses a sale of 4,000 shares at $12.7358 by the EVP, reducing his direct stake to 138,747 shares. This appears to be a straightforward disposition rather than a transaction involving derivatives or a plan-based acquisition. The size of the sale relative to reported post-transaction holdings suggests the reporting person retains a material position. No additional context about purpose or trading plan is provided in the filing.

Corporate Governance Expert

TL;DR Officer sale disclosed properly; signature by attorney-in-fact included.

The filing meets Section 16(a) disclosure requirements by identifying the reporting person, relationship as an officer, transaction details, and post-transaction ownership. The Form 4 includes an attorney-in-fact signature dated 08/18/2025. There is no indication in the filing of Rule 10b5-1 plan use or any amendment. From a governance perspective, the disclosure is routine and complete as submitted.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mentz Christian

(Last) (First) (Middle)

25 MALL ROAD

SUITE 416

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cerence Inc. [ CRNC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Revenue Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	08/14/2025		S		4,000	D	$12.7358	138,747	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale reported on this Form 4 represents shares sold by the Reporting Person.

Remarks:

	/s/ Jennifer Salinas, Attorney-in-Fact	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Cerence (CRNC) insider Christian Mentz report on Form 4?

Christian Mentz reported a sale of 4,000 shares on 08/14/2025 at a price of $12.7358 per share and retained 138,747 shares.

What role does the reporting person hold at Cerence (CRNC)?

The Form 4 lists Christian Mentz as an Officer with the title EVP, Chief Revenue Officer.

Who signed the Form 4 for this transaction?

The Form 4 was signed by Jennifer Salinas, Attorney-in-Fact on 08/18/2025.

Does the Form 4 indicate use of a 10b5-1 trading plan?

No. The filing does not indicate that the transaction was made pursuant to a 10b5-1 plan; no box or remark about a plan is included.

Were any derivative transactions reported in this Form 4?

No. Table II for derivative securities shows no reported transactions; only a non-derivative sale of common stock is listed.